Vimarsana
Biggest News Aggregation in the World

Page 11 - Jin Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jin Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jin Li Today - Breaking & Trending Today

Coronavirus: China's eased zero-Covid rules put to the test as cases spike - Vimarsana News

Coronavirus: China's eased zero-Covid rules put to the test as cases spike

Under recently relaxed rules, regional authorities have been told to stop fresh Covid outbreaks while ensuring they address ‘public demands’.

Source: scmp.com
Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery - Vimarsana News

Daewoong and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

CHENGDU, China, Nov. 13, 2022 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ('HitGen', SSE:688222.SH) today announced that it...

China's Communist Party names health expert Yin Li to top Beijing job - Vimarsana News

China's Communist Party names health expert Yin Li to top Beijing job

Yin moves into position from Fujian, a power base for President Xi Jinping.

Source: scmp.com
Scheduled water service interruption in upper Dandan, Naftan, Obyan - Vimarsana News

Scheduled water service interruption in upper Dandan, Naftan, Obyan

(Commonwealth Utilities Corporation) — There will be a scheduled water service interruption on Friday, Oct. 28, 2022, from 8:30 a.m. to 2:30 p.m. for the Upper Dandan Homestead, Naftan and

Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology - Vimarsana News

Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology

CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased